Surrozen (SRZN) Treasury Shares (2020 - 2026)
Surrozen (SRZN) recorded quarterly Treasury Shares of $811000.0 in Q1 2026, up 605.22% quarter-over-quarter from $115000.0 in Q4 2025, and up 4168.42% on a YoY basis from $19000.0 in Q1 2025.
Surrozen (SRZN) Treasury Shares (2020 - 2026) Analysis & Trends
Surrozen's Treasury Shares history runs 7 years deep, the most recent figure standing at $811000.0 for Q1 2026.
- In Q1 2026, Treasury Shares rose 4168.42% year-over-year to $811000.0; the TTM figure through Mar 2026 stood at $811000.0 (up 4168.42% YoY), while the FY2025 annual figure was $115000.0, up 202.63% from the prior year.
- Treasury Shares was $811000.0 for Q1 2026 at Surrozen, up from $115000.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $811000.0 in Q1 2026 to a low of $130.0 in Q2 2022.
- Historically, Treasury Shares has averaged $102726.1 across 5 years, with a median of $62500.0 in 2023.
- Biggest YoY gain for Treasury Shares was 64934.97% in 2023; the steepest drop was 98.85% in 2023.
- A 5-year view of Treasury Shares shows it stood at $117000.0 in 2022, then decreased by 23.08% to $90000.0 in 2023, then tumbled by 57.78% to $38000.0 in 2024, then soared by 202.63% to $115000.0 in 2025, then surged by 605.22% to $811000.0 in 2026.
- The last three Treasury Shares figures came in at $811000.0 (Q1 2026), $115000.0 (Q4 2025), and $115000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Surrozen | 225,877.86 | -106.68 Mn | - | 811,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 811,000.00 |
| Mar 31, 2026 | 811,000.00 |
| Dec 31, 2025 | 115,000.00 |
| Dec 31, 2025 | 115,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 116,000.00 |
| Jun 30, 2025 | 116,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 44,000.00 |
| Mar 31, 2024 | 44,000.00 |
| Dec 31, 2023 | 90,000.00 |
| Dec 31, 2023 | 90,000.00 |